Raltitrexed
- Generic Name
- Raltitrexed
- Brand Names
- Tomudex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H22N4O6S
- CAS Number
- 112887-68-0
- Unique Ingredient Identifier
- FCB9EGG971
- Background
Raltitrexed (brand name Tomudex®) is a chemotherapy drug manufactured AstraZeneca Company, is an antimetabolite used in chemotherapy. It is an inhibitor of thymidylate synthase.
- Indication
For the treatment of malignant neoplasm of colon and rectum
- Associated Conditions
- Advanced Colorectal Cancer, Pleural Mesotheliomas
Fosun Pharma and MingMed Achieve Key Regulatory Milestones for Novel Therapies
• Fosun Pharma's subsidiary, Jisimei Pharmaceutical, has received marketing approval in China for its Oxaliplatin Injection, a chemotherapeutic agent developed for cancer treatment.
• MingMed Biotechnology's subsidiary, Claruvis Pharmaceutical, has secured FDA IND approval for YY003, a liquid formulation of recombinant Botulinum Toxin Type A (BoNT/A).
• YY003, presented in a pre-filled syringe, is intended for treating glabellar lines and offers a potentially safer and more convenient option for BoNT/A users.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath